ARX788 for Treating Patients With HER2-low Locally Advanced Unresectable or Metastatic Breast Cancer
Abroad (travel likely)RecruitingPHASE2
Conditions
HER2 Low Breast Carcinoma · Triple Negative Breast Cancer · Hormone-receptor-positive Breast Cancer · Hormone Receptor Positive Breast Carcinoma
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
University of California, San Francisco, San Francisco, California, United States
Contact: Principal Investigator (Laura Huppert, MD)
Study leads
Laura Huppert, MD
Principal Investigator
University of California, San Francisco